DOXA

News

Stay current on specialty insurance trends, market insights, and news from across the DOXA platform. From industry developments and expert perspectives to program updates and company milestones, tap into the pulse of specialty insurance.

#
The DOXA Difference: A People-First Platform Built for Specialty Insurance

Specialty insurance is a people-driven business. The most innovative coverage solutions for hard-to-place ...

Continue Reading
#
What It Takes to Launch a Successful MGA: 6 Key Insights

Managing General Agents (MGAs) are outpacing much of the insurance market, making them a hot commodity for ...

Continue Reading
#
DOXA: Launching MGAs with Confidence and Expertise

  Starting a Managing General Agency (MGA) can be both thrilling and overwhelming. You’ve got the vision. You ...

Continue Reading
#
DOXA: Marine Insurance in 2025: Cybersecurity & Compliance

  In today’s increasingly digitized world, the U.S. Marine Transportation System (MTS) stands as a vital ...

Continue Reading
#
Accurate Hierarchies, Trusted Partnerships: How DOXA Unlocks Scalable Commission Management

  In insurance, strong partnerships aren’t just built on goodwill. They’re built on accuracy, speed, and ...

Continue Reading
#
The Hidden Power of Adjuster Management: How DOXA Helped an Insurance Services Firm Unlock Scale, Compliance, and Growth

    In the world of property and casualty claims, efficiency isn’t just a nice-to-have—it’s a business ...

Continue Reading
#
Scaling People, Not Just Revenue: The Hidden Lever for Sustainable Growth in Insurance Brokerages

  In the independent insurance brokerage world, growth is often treated as the endgame. Agencies and ...

Continue Reading
#
The New Learning Loop: Trust, AI, and the Future of Insurance Innovation

Every year, the Tech Vision report offers a compelling lens into the future of technology, and for its 25th ...

Continue Reading
#
Generating Consistent Organic Growth in a Challenging Market

Growth is more than a KPI—it’s a signal of vitality, relevance, and long-term viability. At DOXA, we view ...

Continue Reading